Shares of Proteome Sciences plc (LON:PRM – Get Free Report) reached a new 52-week low on Wednesday . The company traded as low as GBX 2.50 ($0.03) and last traded at GBX 2.63 ($0.03), with a volume of 1980 shares changing hands. The stock had previously closed at GBX 3.01 ($0.04).
Proteome Sciences Stock Up 10.7 %
The company has a 50-day moving average of GBX 3.07 and a 200-day moving average of GBX 3.40. The company has a market cap of £9.15 million, a PE ratio of -310.00 and a beta of 0.07.
About Proteome Sciences
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Recommended Stories
- Five stocks we like better than Proteome Sciences
- The Significance of Brokerage Rankings in Stock Selection
- Texas Roadhouse Stock Steering for New Highs This Year
- Differences Between Momentum Investing and Long Term Investing
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- What Are Dividend Challengers?
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
